We are driven by our mission to advance the development of new treatments.
Medidata’s journey started in 1999 when a scientist working on his first clinical trial waded through inefficiencies and delays, and knew that technology could improve the process. Over time, we’ve grown to be the leader in clinical technology, with thousands of people working towards the same goal: using the latest technology to help our life science clients bring their life-saving new treatments to the public.
Medidata co-founder Tarek Sherif assumed the full-time role of Life Sciences & Healthcare Sector board Chairman for Dassault Systèmes in July 2021.
Over the span of 20 years, in his role as CEO, Sherif led Medidata from startup to becoming one of the leading global providers of cloud-based solutions to the life science industry and the largest in clinical development, while defining the vertical cloud company business model. Medidata is the most-used platform for clinical trials around the world, powering tens of thousands of clinical trials, with millions of patients. Medidata is now also redefining the patient experience in clinical trials and is helping customers use the power of data and AI to bring safer drugs to market more quickly. In 2019, in one of the largest healthcare technology acquisitions in history, Medidata became part of Dassault Systemes.
Sherif has more than 35 years of leadership experience in health-tech and finance. Prior to Medidata, he co-managed and managed equity funds focused on public and private technology and life sciences companies, as well as holding various positions in finance.
Sherif received his BA in economics from Yale University in 1984 and graduated from Columbia Business School in 1991, where he earned a degree in business administration and finance. He serves as the co-chair of the Partnership Fund for New York City, which is focused on creating business opportunities and jobs for city residents. Tarek also sits on the advisory board of Students on Ice, a not-for-profit organization focused on inspiring youth through educational expeditions to the polar regions, and the Musculoskeletal Advisory Board at NYU Langone Medical Center.
Medidata co-founder Glen de Vries was named Life Sciences & Healthcare Vice-Chair for Dassault Systèmes in July 2021.
de Vries drove Medidata’s mission, from 1999 through Medidata’s acquisition by Dassault Systèmes in 2019, of “powering smarter treatments and healthier people” by advancing transformation in clinical research with technology, non-traditional ways of thinking, and industry collaboration. Over more than two decades, de Vries worked with the largest pharma companies, small biotechs, and medical device companies across tens-of-thousands of clinical trials.
As the Vice-Chair of Life Sciences and Healthcare, he leverages the Medidata platform, including billions of records from millions of patient volunteers across virtually every therapeutic area, along with the broader scientific, manufacturing and virtual twin capabilities of 3DS to transform not just the creation of new therapies, but their ultimate delivery to patients around the world.
Articles and papers by de Vries have appeared in Applied Clinical Trials, Cancer, The Journal of Urology, Molecular Diagnostics, and other journals. He serves as a trustee of Carnegie Mellon University and is the author of The Patient Equation (de Vries & Blachman, 2020).
de Vries received his undergraduate degree in molecular biology and genetics from Carnegie Mellon University, worked as a research scientist at the Columbia Presbyterian Medical Center, and studied computer science at New York University's Courant Institute of Mathematics.
Sastry Chilukuri was named co-CEO of Medidata in July 2021. Chilukuri is also the Founder & President of Acorn AI, Medidata’s Data Science business.
Chilukuri brings over 22 years of expertise in healthcare technology. Before joining Medidata, he was a partner at McKinsey & Company, where he worked for 12 years advising bio-pharma, medical device, technology, PE and public sector clients around the world. Prior to that, he worked for GE Healthcare in software engineering, product development and operations.
He is a sought after board member currently serving on the boards of Dassault Systemes Life Sciences & Healthcare sector and Cyclica, a data-driven drug discovery company.
His perspectives have been widely disseminated, including conferences, media and numerous publications on McKinsey Insights. He holds multiple patents.
Chilukuri holds a Master of Business Administration from the Kellogg School of Management, Northwestern University; a Master of Science from The Ohio State University and a Bachelor of Technology (B. Tech) from the Indian Institute of Technology (BHU), Varanasi, India.
Dr. Rama Kondru was named co-CEO of Medidata in July 2021.
An innovative and inspiring leader with over 20 years of experience in pharma, medical devices, data science, and academia, Dr. Kondru previously served as 3DS Medidata EVP, Chief Technology Officer and Head of Product overseeing the R&D organization with a focus on patient centricity, engineering excellence and analytics. In 2020, Dr. Kondru was named a top 100 life sciences leader by PharmaVOICE.
Dr. Kondru joined 3DS Medidata in 2019 from Janssen Americas, a Johnson and Johnson company, where he held a global commercial technology role as Senior Vice President and CIO for Janssen Pharmaceuticals - Americas, and, before that, a CIO role overseeing R&D and Innovation in the J&J Medical Devices group. He had also served as Global Head of Data Sciences and Advanced Analytics at J&J.
Prior to Janssen, Dr. Kondru held leadership and scientific roles at UCB Pharma and Hoffmann-La Roche.
Dr. Kondru is well recognized in the industry, having received multiple innovation awards and been named author on over 25 patents and 30 peer-reviewed scientific publications. He has an undergraduate degree from the Indian Institute of Technology, Mumbai, and a Ph.D. in computational sciences from the University of Pittsburgh. He completed post-doctoral research at the University of Pittsburgh Medical School and served as an adjunct professor at Duke University.
Anthony Costello is CEO, Patient Cloud at Dassault Systèmes.
In this role, Costello leads the development of Medidata’s patient-facing activities and solutions including de-centralized trials technology and strategy, Patient Cloud product apps, myMedidata patient portal, Disease Registries and Recruitment, Telehealth and Virtual Visits, and Sensor Cloud and Biomarker Discovery.
Over his 25+ year career in the clinical research industry, he has focused on disruptive and innovative technology that can simplify clinical trials for patients, sites, and sponsors. Costello began his career in the oncology research program at Genentech where he focused primarily on Herceptin and Avastin global research studies. After leaving Genentech, he went on to co-found several clinical trials technology start-up companies including EDC start-up, Nextrials (acquired by PRA Health Sciences) where he was co-founder and VP of Product Development and Virtual Trials and eConsent pioneering start-up, Mytrus (acquired by Medidata) where he was co-founder and CEO. After the acquisition of Mytrus, Costello joined the Medidata Patient Cloud team as Vice President of Mobile Health and has since taken the leadership role of the Brand as well as a position within the Medidata Senior Leadership Team where he helps to set product strategy across all of the products and capabilities on the Medidata Platform.
Costello has been recognized as one of the PharmaVoice Top 100 Most Inspiring People in Clinical Research, has served as Chairman of the Board for the Society for Clinical Data Management and is currently a member of the editorial advisory board for Applied Clinical Trials magazine. He is a frequent author and presenter on topics related to the efficient use of technology in clinical research, and has a degree in Sociology from UC Berkeley.
Rouven Bergmann is chief operating officer (COO) Life Sciences for Dassault Systèmes.
In this position, Bergmann continues to oversee Medidata’s operations while also expanding his responsibilities to help shape the future of the company’s Life Science strategy. He will be ensuring the focused execution of plans across the life sciences portfolio.
Previously, Bergmann served as chief operating officer for Medidata where he oversaw the company’s strategic finance, capital management, pricing, tax, controllership, procurement operations, expense management and treasury.
Bergmann, who joined Medidata in 2015, led the financial strategy of growing the business from $300M to more than $700M at the time of the acquisition by Dassault Systèmes in 2019. With the acquisition, he transitioned his responsibilities as a public company CFO to COO responsible for managing the execution plan of the acquisition and day-to-day global operations of Medidata.
Prior to joining Medidata, Bergmann was CFO of SAP North America, a multi-billion dollar software business, where he was responsible for overseeing all financial activities for SAP’s largest business unit. His key accomplishments include driving SAP’s transition from a traditional licensing model to SaaS and leading transformational acquisition integrations. Since joining SAP in 2005, Rouven served as chief operating officer for SAP’s global R&D organization, as well as held key leadership roles in Germany; Bangalore, India; and the U.S. in Palo Alto, California and NYC.
Bergmann holds master’s degrees in mechanical engineering and business administration from the Technical University of Kaiserslautern in Germany, and a PhD in economics and finance from the University of Munich in Germany.
Naveen Bhateja is the EVP, Chief People Officer at Medidata leading all aspects of human resources including recruiting, workplace solutions, and diversity and inclusion teams globally. As a member of the senior leadership team, Bhateja operates as a business strategist and trusted advisor, and believes that people strategies empower successful business outcomes.
Prior to joining Medidata, he was global vice president of HR for Juniper Networks for five years supporting 50 countries. In this role, Bhateja led several companywide transformational initiatives including an overhaul to workforce planning process that saved over $200M in operational expenses to support reinvestment in strategic areas. Naveen’s career spans nearly 25 years at companies including GE, JP Morgan Chase, Experian and Amazon. Naveen also serves on a non-profit board for Geeks Rule and as a pro-bono account Director at Taproot Foundation.
Bhateja earned an MBA from the University of Leeds, UK and trained in design thinking at Stanford University.
Rick Goldstein serves as General Counsel at Medidata.
Goldstein leads Medidata’s business-focused Legal team, which supports the company’s commercial relationships, protects the company’s intellectual property, advises on data privacy and protection regulations, identifies and mitigates enterprise risk, and guides Medidata through the cutting-edge legal issues attendant to creating transformative technology and data analysis products.
Prior to Medidata, Goldstein was a partner at Orrick, Herrington & Sutcliffe LLP, a leading global law firm, where he represented some of the world’s best-known technology and pharmaceutical companies in antitrust, intellectual property, and other complex commercial litigation and investigations. Earlier in his career, Goldstein was Deputy General Counsel at Internet advertising pioneer DoubleClick Inc., and was a member of the commercial/legal team at Merck & Co., Inc. He received a JD from New York University School of Law, and a Bachelor of Arts from the University of Pennsylvania.
Jackie Kent serves as Chief Customer Officer at Medidata.
Kent leads the newly created Customer Solutions and Success (CSS) organization, which is laser-focused on ensuring the delivery of a positive experience for customers along every step of their journey with the company. The CSS organization uses a cross-functional customer strategy to ensure that the voice of the customer is infused throughout the organization, delivering value through innovative solutions meeting the most important needs of the industry and patients.
Prior to joining Medidata, Kent spent 28 years at Eli Lilly, starting with technical IT and moving into leadership roles across Clinical Development. She developed a comprehensive knowledge of information technology, clinical trial design and execution, as well as clinical trial supply planning. Kent also had accountability for the IT systems that supported these teams, including the Clinical Trial MRP system (SAP) and the Lilly IRT system.
Kent serves as vice-chair of the Association of Clinical Research Organizations (ACRO) and is a member of the Society of Clinical Research Sites (SCRS) Leadership Council. She received a bachelor's degree in Computer Science from Butler University.
Wendy Lurrie serves as senior vice president of global marketing at Medidata. She has responsibility for all aspects of how Medidata markets and communicates its portfolio of brands to key audiences and constituencies. This includes the creation of innovative marketing strategies that build the brand and business, and partnering with sales and services to meet revenue goals.
She is a proven healthcare marketing leader with unmatched experience in driving innovation, growth, culture, and results. Prior to Medidata, Lurrie spent over 30 years across the full spectrum of marketing disciplines, including brand, direct marketing, CRM, digital marketing, and integrated marketing. Most recently she was the president of gyro NY and the founder of gyro:human, the agency’s first healthcare practice. Lurrie has also held senior positions at Grey and FCB, and co-founded SPUR partners, a marketing and strategy consultancy.
Lurie was named a Working Mother of the Year in 2008, and has written widely published articles about healthcare and B2B marketing. Her bachelor's degree and graduate work were in English and linguistics at New York University.
Michael Pray serves as Chief Commercial Officer of Life Science Engagement at Dassault Systèmes. Pray leads the commercial go-to-market team responsible for global sales of Dassault Systèmes brands and solutions into the Life Sciences sector.
With more than 25 years of industry experience, Pray has a proven track record of building and scaling high-performing sales teams in both start-up and high-growth environments. Since 2016, Pray was EVP and General Manager of Medidata's global commercial organization prior to its acquisition by Dassault Systèmes.
Pray previously served as chief revenue officer of Tangoe, a global technology company that provides cloud solutions to effectively manage IT assets and services. Before Tangoe, he spent 14 years within IBM's software group that included a series of executive positions with roles of increasing responsibility. He served as VP of worldwide analytic solution sales, where he was responsible for sales, technical sales and channels that drove over $1.5B in annual revenue.
Pray earned a bachelor's degree from the University of Michigan in Ann Arbor.
Tobias Schaefer is the chief financial officer (CFO) of Medidata.
Schaefer is responsible for overseeing the company’s finance activities, including commercial finance, pricing, financial planning and analysis, controllership, procurement, tax and finance operations. Schaefer and his team partner with leaders across the organization to implement financial strategies that drive forward the company's strategic and operational objectives.
Since joining Medidata in 2016, Schaefer has held financial leadership roles with increasing responsibility, helping to build the finance team that supports the company’s rapid growth path. Most recently, he served as SVP Finance, overseeing Medidata’s financial planning, controllership and procurement organizations. Schaefer was also instrumental in the due diligence activities leading up to Dassault Systèmes’ acquisition of Medidata.
Prior to joining Medidata, Schaefer was vice president, finance at Siemens Healthcare’s Laboratory Diagnostics business, where he was responsible for leading all finance activities related to the multi-year development and market introduction of major new products. Since joining Siemens in 2009, Schaefer held several senior finance roles at the company in Germany and the United States.
Schaefer received his Bachelor of Science degree in International Business from Northeastern University and holds a degree in finance from the European School of Business in Reutlingen, Germany.
Joe Schmidt is the executive vice president of Professional Services at Medidata, a Dassault Systèmes company. Schmidt leads a global team that supports over 2,000 clients, delivering services from product configuration, ongoing study support, strategic consulting, digital transformations, study management, analytics and platform management.
Schmidt has over 25 years of experience building and leading teams in the clinical research industry, largely focused on technology enabled solutions that help bring better treatments to patients, faster. Schmidt joined Medidata in 2017 supporting enterprise clients and created the patient cloud services team whose focus is supporting mobile, patient facing and decentralized clinical trial solutions.
Schmidt previously served as the chief operating officer of Clinical Ink. Before Clinical Ink, he spent 10 years with MedAvante (now WCG), as executive vice president and general manager, leading the solution development and global expansion activities. Schmidt started his career at Covance working in clinical operations with roles of increasing responsibility. Schmidt has a bachelor’s degree in biology from the University of Scranton.